Manufacturer:

Amgen

Name:

KANJINTI

Category:

Q Code

HCPCS:

Q5117

NDC(s):

55513-0132-01, 55513-0141-01,

Primary Type:

Biosimilar

Route of Administration:

Intravenous

About:

KANJINTI is a Biosimilar drug manufactured by Amgen and administered via the Intravenous route of administration. The Q Code: Q5117 is aligned to the drug KANJINTI.